Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.834
Filter
1.
Bull Exp Biol Med ; 176(5): 595-598, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38724816

ABSTRACT

A large-scale search for the genetic variants with a bias in the representation of alleles in transcriptome data (AE SNPs) and the binding sites in microRNA 3'-UTRs was performed and their functional significance was assessed using massively parallel reporter assay (MPRA). Of the 629,559 associated "SNP-gene" pairs (eQTLs) discovered in the human liver tissue according to the GTEx Analysis V8 data, 4394 polymorphic positions in the 3'-UTRs of the genes, which represent the eQTLs for these genes were selected. The TargetScanHuman 7.0 algorithm and PolymiRTS database were searched for the potential microRNA-binding sites. Of the predicted microRNA sites affected by eQTL-SNPs, we selected 51 sites with the best evidence of functionality according to Ago2-CLIP-seq, CLEAR-CLIP, and eCLIP-seq for RNA-binding proteins. For MPRA, a library of the plasmids carrying the main and alternative alleles for each AE SNP (in total, 102 constructs) was created. Allele-specific expression for 6 SNPs was detected by transfection of the HepG2 cell line with the constructed plasmid library and sequencing of target DNA and RNA sequences using the Illumina (MiSeq) platform.


Subject(s)
3' Untranslated Regions , Alleles , MicroRNAs , Polymorphism, Single Nucleotide , Humans , Polymorphism, Single Nucleotide/genetics , MicroRNAs/genetics , MicroRNAs/metabolism , Hep G2 Cells , Binding Sites/genetics , 3' Untranslated Regions/genetics , High-Throughput Nucleotide Sequencing/methods , Genes, Reporter/genetics , Liver/metabolism , Argonaute Proteins/genetics , Argonaute Proteins/metabolism , Transcriptome/genetics
2.
STAR Protoc ; 5(2): 103084, 2024 Jun 21.
Article in English | MEDLINE | ID: mdl-38787727

ABSTRACT

Human pluripotent stem cells (hPSCs) hold great promise for applications in regenerative medicine and disease modeling. Here, we present a protocol for establishing edited hPSC cell lines utilizing visualized orthogonal selective reporters. We describe steps for constructing plasmids, carrying out cell culture and electroporation, as well as performing drug-fluorescent dual enrichment, clone screening, and cell line characterization. This protocol facilitates the achievement of single-base homozygous mutations and reporter knockins, offering a reliable approach for precision genome editing.


Subject(s)
Gene Editing , Pluripotent Stem Cells , Humans , Gene Editing/methods , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Electroporation/methods , CRISPR-Cas Systems/genetics , Genes, Reporter/genetics , Cell Line , Cell Culture Techniques/methods , Plasmids/genetics
3.
Anal Chem ; 96(19): 7444-7451, 2024 May 14.
Article in English | MEDLINE | ID: mdl-38684052

ABSTRACT

Next-generation sequencing offers highly multiplexed and accurate detection of nucleic acid sequences but at the expense of complex workflows and high input requirements. The ease of use of CRISPR-Cas12 assays is attractive and may enable highly accurate detection of sequences implicated in, for example, cancer pathogenic variants. CRISPR assays often employ end-point measurements of Cas12 trans-cleavage activity after Cas12 activation by the target; however, end point-based methods can be limited in accuracy and robustness by arbitrary experimental choices. To overcome such limitations, we develop and demonstrate here an accurate assay targeting a mutation of the epidermal growth factor gene implicated in lung cancer (exon 19 deletion). The assay is based on characterizing the kinetics of Cas12 trans-cleavage to discriminate the mutant from wild-type targets. We performed extensive experiments (780 reactions) to calibrate key assay design parameters, including the guide RNA sequence, reporter sequence, reporter concentration, enzyme concentration, and DNA target type. Interestingly, we observed a competitive reaction between the target and reporter molecules that has important consequences for the design of CRISPR assays, which use preamplification to improve sensitivity. Finally, we demonstrate the assay on 18 tumor-extracted amplicons and 100 training iterations with 99% accuracy and discuss discrimination parameters and models to improve wild type versus mutant classification.


Subject(s)
Gene Deletion , Genes, erbB-1 , Genotyping Techniques , Genotyping Techniques/instrumentation , Genotyping Techniques/methods , Genotyping Techniques/standards , Genes, Reporter/genetics , Genes, erbB-1/genetics , Humans , RNA, Guide, CRISPR-Cas Systems/genetics , RNA, Guide, CRISPR-Cas Systems/metabolism , Lung Neoplasms/diagnosis , Lung Neoplasms/genetics , Reproducibility of Results
4.
ACS Synth Biol ; 13(4): 1365-1372, 2024 04 19.
Article in English | MEDLINE | ID: mdl-38518262

ABSTRACT

Lactococcus cremoris (homotypic synonym: Lactococcus lactis) is receiving increasing attention as a prominent vehicle for the delivery of live vaccines. This can hardly be achieved without developing tools for the genetic manipulation of L. cremoris, and the paucity of studies on L. cremoris endogenous promoters has attracted our attention. Here, we report the discovery and characterization of 29 candidate promoters identified from L. cremoris subsp. cremoris NZ9000 by RNA sequencing analysis. Furthermore, 18 possible constitutive promoters were obtained by RT-qPCR screening from these 29 candidate promoters. Then, these 18 promoters were cloned and characterized by a reporter gene, gusA, encoding ß-glucuronidase. Eventually, eight endogenous constitutive promoters of L. cremoris were obtained, which can be applied to genetic manipulation of lactic acid bacteria.


Subject(s)
Lactococcus lactis , Lactococcus , Lactococcus lactis/genetics , Lactococcus lactis/metabolism , Promoter Regions, Genetic/genetics , Genes, Reporter/genetics , Gene Expression
5.
Virol Sin ; 39(3): 447-458, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38548102

ABSTRACT

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still epidemic around the world. The manipulation of SARS-CoV-2 is restricted to biosafety level 3 laboratories (BSL-3). In this study, we developed a SARS-CoV-2 ΔN-GFP-HiBiT replicon delivery particles (RDPs) encoding a dual reporter gene, GFP-HiBiT, capable of producing both GFP signal and luciferase activities. Through optimal selection of the reporter gene, GFP-HiBiT demonstrated superior stability and convenience for antiviral evaluation. Additionally, we established a RDP infection mouse model by delivering the N gene into K18-hACE2 KI mouse through lentivirus. This mouse model supports RDP replication and can be utilized for in vivo antiviral evaluations. In summary, the RDP system serves as a valuable tool for efficient antiviral screening and studying the gene function of SARS-CoV-2. Importantly, this system can be manipulated in BSL-2 laboratories, decreasing the threshold of experimental requirements.


Subject(s)
Antiviral Agents , COVID-19 , Genes, Reporter , Green Fluorescent Proteins , SARS-CoV-2 , Animals , SARS-CoV-2/genetics , Genes, Reporter/genetics , Mice , Antiviral Agents/pharmacology , COVID-19/virology , COVID-19/diagnosis , Humans , Green Fluorescent Proteins/genetics , Disease Models, Animal , Virus Replication , High-Throughput Screening Assays/methods , Luciferases/genetics , Replicon/genetics , HEK293 Cells
6.
Nucleic Acids Res ; 52(6): e34, 2024 Apr 12.
Article in English | MEDLINE | ID: mdl-38375914

ABSTRACT

Nonsense-mediated mRNA decay (NMD) is a network of pathways that degrades transcripts that undergo premature translation termination. In mammals, NMD can be divided into the exon junction complex (EJC)-enhanced and EJC-independent branches. Fluorescence- and luminescence-based reporters have long been effective tools to investigate NMD, yet existing reporters largely focus on the EJC-enhanced pathway. Here, we present a system of reporters for comparative studies of EJC-independent and EJC-enhanced NMD. This system also enables the study of NMD-associated outcomes such as premature termination codon (PTC) readthrough and truncated protein degradation. These reporters are compatible with fluorescence or luminescence-based readouts via transient transfection or stable integration. Using this reporter system, we show that EJC-enhanced NMD RNA levels are reduced by 2- or 9-fold and protein levels are reduced by 7- or 12-fold compared to EJC-independent NMD, depending on the reporter gene used. Additionally, the extent of readthrough induced by G418 and an NMD inhibitor (SMG1i), alone and in combination, varies across NMD substrates. When combined, G418 and SMG1i increase readthrough product levels in an additive manner for EJC-independent reporters, while EJC-enhanced reporters show a synergistic effect. We present these reporters as a valuable toolkit to deepen our understanding of NMD and its associated mechanisms.


Subject(s)
Exons , Genes, Reporter , Genetic Techniques , Nonsense Mediated mRNA Decay , Exons/genetics , Nonsense Mediated mRNA Decay/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Humans , HEK293 Cells , Genes, Reporter/genetics
7.
Biotechnol J ; 19(1): e2300254, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37750498

ABSTRACT

The novel mosquito-borne Tembusu virus (TMUV, family Flaviviridae) was discovered as the cause of a severe outbreak of egg-drop syndrome affecting ducks in Southeast Asia in 2010. TMUV infection can also lead to high mortality in various additional avian species such as geese, pigeons, and chickens. This study describes the construction of an infectious cDNA clone of a contemporary duck-isolate (TMUV WU2016). The virus recovered after transfection of BHK-21 cells shows enhanced virus replication compared to the mosquito-derived MM1775 strain. Next, the WU2016 cDNA clone was modified to create a SP6 promoter-driven, self-amplifying mRNA (replicon) capable of expressing a range of different reporter genes (Renilla luciferase, mScarlet, mCherry, and GFP) and viral (glyco)proteins of avian influenza virus (AIV; family Orthomyxoviridae), infectious bursal disease virus (IDBV; family Bunyaviridae) and infectious bronchitis virus (IBV; family Coronaviridae). The current study demonstrates the flexibility of the TMUV replicon system, to produce different heterologous proteins over an extended period of time and its potential use as a platform technology for novel poultry vaccines.


Subject(s)
Culicidae , Flavivirus Infections , Flavivirus , Poultry Diseases , Animals , Flavivirus Infections/veterinary , Flavivirus Infections/genetics , Poultry/genetics , Genes, Reporter/genetics , DNA, Complementary , Antigens, Heterophile , Poultry Diseases/genetics , Chickens , Flavivirus/genetics , Ducks/genetics , Clone Cells , Replicon
8.
Biotechniques ; 75(6): 250-255, 2023 12.
Article in English | MEDLINE | ID: mdl-37880975

ABSTRACT

Fluorescent proteins, such as green fluorescent proteins, are invaluable tools for detecting and quantifying gene expression in high-throughput reporter gene assays. However, they introduce significant inaccuracies in studies involving microaerobiosis or anaerobiosis, as oxygen is required for the maturation of these proteins' chromophores. In this study, the authors highlight the errors incurred by using fluorescent proteins under limited oxygenation by comparing standard fluorescence-based reporter gene assays to quantitative real-time PCR data in the study of a complex oxygen-regulated gene network. Furthermore, a solution to perform quantification of anaerobic and microaerobic gene expression with fluorescent reporter proteins using a microplate reader with an oxygen control system and applying pulses of full oxygenation before fluorescence measurements is provided.


Subject(s)
Oxygen , Anaerobiosis , Genes, Reporter/genetics , Green Fluorescent Proteins/analysis , Indicators and Reagents , Gene Expression , Oxygen/metabolism , Luminescent Proteins/genetics , Luminescent Proteins/metabolism
9.
Nature ; 616(7957): 495-503, 2023 04.
Article in English | MEDLINE | ID: mdl-37046085

ABSTRACT

Skates are cartilaginous fish whose body plan features enlarged wing-like pectoral fins, enabling them to thrive in benthic environments1,2. However, the molecular underpinnings of this unique trait remain unclear. Here we investigate the origin of this phenotypic innovation by developing the little skate Leucoraja erinacea as a genomically enabled model. Analysis of a high-quality chromosome-scale genome sequence for the little skate shows that it preserves many ancestral jawed vertebrate features compared with other sequenced genomes, including numerous ancient microchromosomes. Combining genome comparisons with extensive regulatory datasets in developing fins-including gene expression, chromatin occupancy and three-dimensional conformation-we find skate-specific genomic rearrangements that alter the three-dimensional regulatory landscape of genes that are involved in the planar cell polarity pathway. Functional inhibition of planar cell polarity signalling resulted in a reduction in anterior fin size, confirming that this pathway is a major contributor to batoid fin morphology. We also identified a fin-specific enhancer that interacts with several hoxa genes, consistent with the redeployment of hox gene expression in anterior pectoral fins, and confirmed its potential to activate transcription in the anterior fin using zebrafish reporter assays. Our findings underscore the central role of genome reorganization and regulatory variation in the evolution of phenotypes, shedding light on the molecular origin of an enigmatic trait.


Subject(s)
Animal Fins , Biological Evolution , Genome , Genomics , Skates, Fish , Animals , Animal Fins/anatomy & histology , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Skates, Fish/anatomy & histology , Skates, Fish/genetics , Zebrafish/genetics , Genes, Reporter/genetics
10.
Nat Commun ; 14(1): 2001, 2023 04 10.
Article in English | MEDLINE | ID: mdl-37037805

ABSTRACT

DNA is a universal and programmable signal of living organisms. Here we develop cell-based DNA sensors by engineering the naturally competent bacterium Bacillus subtilis (B. subtilis) to detect specific DNA sequences in the environment. The DNA sensor strains can identify diverse bacterial species including major human pathogens with high specificity. Multiplexed detection of genomic DNA from different species in complex samples can be achieved by coupling the sensing mechanism to orthogonal fluorescent reporters. We also demonstrate that the DNA sensors can detect the presence of species in the complex samples without requiring DNA extraction. The modularity of the living cell-based DNA-sensing mechanism and simple detection procedure could enable programmable DNA sensing for a wide range of applications.


Subject(s)
Bacillus subtilis , Bacteria , Biosensing Techniques , Cell Engineering , DNA, Bacterial , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Bacteria/pathogenicity , Bacillus subtilis/genetics , Bacillus subtilis/growth & development , Biosensing Techniques/methods , Humans , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Fluorescence , Microbial Viability , Synthetic Biology , Gene Regulatory Networks/genetics , Genes, Reporter/genetics , In Vitro Techniques , Escherichia coli/classification , Escherichia coli/genetics , Escherichia coli/isolation & purification , Bacterial Infections/microbiology
11.
Nature ; 616(7956): 365-372, 2023 04.
Article in English | MEDLINE | ID: mdl-37020022

ABSTRACT

Human gene expression is regulated by more than 2,000 transcription factors and chromatin regulators1,2. Effector domains within these proteins can activate or repress transcription. However, for many of these regulators we do not know what type of effector domains they contain, their location in the protein, their activation and repression strengths, and the sequences that are necessary for their functions. Here, we systematically measure the effector activity of more than 100,000 protein fragments tiling across most chromatin regulators and transcription factors in human cells (2,047 proteins). By testing the effect they have when recruited at reporter genes, we annotate 374 activation domains and 715 repression domains, roughly 80% of which are new and have not been previously annotated3-5. Rational mutagenesis and deletion scans across all the effector domains reveal aromatic and/or leucine residues interspersed with acidic, proline, serine and/or glutamine residues are necessary for activation domain activity. Furthermore, most repression domain sequences contain sites for small ubiquitin-like modifier (SUMO)ylation, short interaction motifs for recruiting corepressors or are structured binding domains for recruiting other repressive proteins. We discover bifunctional domains that can both activate and repress, some of which dynamically split a cell population into high- and low-expression subpopulations. Our systematic annotation and characterization of effector domains provide a rich resource for understanding the function of human transcription factors and chromatin regulators, engineering compact tools for controlling gene expression and refining predictive models of effector domain function.


Subject(s)
Gene Expression Regulation , Mutagenesis , Protein Domains , Transcription Factors , Transcription, Genetic , Humans , Chromatin/genetics , Chromatin/metabolism , Genes, Reporter/genetics , Transcription Factors/chemistry , Transcription Factors/genetics , Transcription Factors/metabolism , Protein Domains/genetics , Repressor Proteins/chemistry , Repressor Proteins/genetics , Repressor Proteins/metabolism , Sumoylation
12.
J Biol Chem ; 299(4): 104599, 2023 04.
Article in English | MEDLINE | ID: mdl-36907438

ABSTRACT

Immune cells adopt a variety of metabolic states to support their many biological functions, which include fighting pathogens, removing tissue debris, and tissue remodeling. One of the key mediators of these metabolic changes is the transcription factor hypoxia-inducible factor 1α (HIF-1α). Single-cell dynamics have been shown to be an important determinant of cell behavior; however, despite the importance of HIF-1α, little is known about its single-cell dynamics or their effect on metabolism. To address this knowledge gap, here we optimized a HIF-1α fluorescent reporter and applied it to study single-cell dynamics. First, we showed that single cells are likely able to differentiate multiple levels of prolyl hydroxylase inhibition, a marker of metabolic change, via HIF-1α activity. We then applied a physiological stimulus known to trigger metabolic change, interferon-γ, and observed heterogeneous, oscillatory HIF-1α responses in single cells. Finally, we input these dynamics into a mathematical model of HIF-1α-regulated metabolism and discovered a profound difference between cells exhibiting high versus low HIF-1α activation. Specifically, we found cells with high HIF-1α activation are able to meaningfully reduce flux through the tricarboxylic acid cycle and show a notable increase in the NAD+/NADH ratio compared with cells displaying low HIF-1α activation. Altogether, this work demonstrates an optimized reporter for studying HIF-1α in single cells and reveals previously unknown principles of HIF-1α activation.


Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit , Transcriptional Activation , Animals , Mice , Genes, Reporter/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Hypoxia-Inducible Factor-Proline Dioxygenases/antagonists & inhibitors , Interferon-gamma/pharmacology , Mitochondria/metabolism , Models, Biological , Prolyl Hydroxylases/metabolism , RAW 264.7 Cells , Single-Cell Analysis/methods , Transcriptional Activation/drug effects
13.
J Biol Chem ; 299(5): 104639, 2023 05.
Article in English | MEDLINE | ID: mdl-36965614

ABSTRACT

Luciferase-based gene reporters generating bioluminescence signals are important tools for biomedical research. Amongst the luciferases, flavin-dependent enzymes use the most economical chemicals. However, their applications in mammalian cells are limited due to their low signals compared to other systems. Here, we constructed Flavin Luciferase from Vibrio campbellii (Vc) for Mammalian Cell Expression (FLUXVc) by engineering luciferase from V. campbellii (the most thermostable bacterial luciferase reported to date) and optimizing its expression and reporter assays in mammalian cells which can improve the bioluminescence light output by >400-fold as compared to the nonengineered version. We found that the FLUXVc reporter gene can be overexpressed in various cell lines and showed outstanding signal-to-background in HepG2 cells, significantly higher than that of firefly luciferase (Fluc). The combined use of FLUXVc/Fluc as target/control vectors gave the most stable signals, better than the standard set of Fluc(target)/Rluc(control). We also demonstrated that FLUXVc can be used for testing inhibitors of the NF-κB signaling pathway. Collectively, our results provide an optimized method for using the more economical flavin-dependent luciferase in mammalian cells.


Subject(s)
Biotechnology , Genes, Reporter , Luciferases , Luminescent Measurements , Animals , Genes, Reporter/genetics , Luciferases/genetics , Luciferases/metabolism , Luminescent Measurements/standards , Mammals/metabolism , Vibrio/enzymology , Recombinant Fusion Proteins/metabolism , Genetic Vectors , Biotechnology/methods
14.
Nat Genet ; 55(2): 346-354, 2023 02.
Article in English | MEDLINE | ID: mdl-36635387

ABSTRACT

Massively parallel reporter gene assays are key tools in regulatory genomics but cannot be used to identify cell-type-specific regulatory elements without performing assays serially across different cell types. To address this problem, we developed a single-cell massively parallel reporter assay (scMPRA) to measure the activity of libraries of cis-regulatory sequences (CRSs) across multiple cell types simultaneously. We assayed a library of core promoters in a mixture of HEK293 and K562 cells and showed that scMPRA is a reproducible, highly parallel, single-cell reporter gene assay that detects cell-type-specific cis-regulatory activity. We then measured a library of promoter variants across multiple cell types in live mouse retinas and showed that subtle genetic variants can produce cell-type-specific effects on cis-regulatory activity. We anticipate that scMPRA will be widely applicable for studying the role of CRSs across diverse cell types.


Subject(s)
Genes, Reporter , HEK293 Cells , Animals , Humans , Mice , Gene Library , Genes, Reporter/genetics , Promoter Regions, Genetic , Retina/metabolism
15.
Nat Biotechnol ; 41(7): 919-931, 2023 Jul.
Article in English | MEDLINE | ID: mdl-36593411

ABSTRACT

Ultrasound allows imaging at a much greater depth than optical methods, but existing genetically encoded acoustic reporters for in vivo cellular imaging have been limited by poor sensitivity, specificity and in vivo expression. Here we describe two acoustic reporter genes (ARGs)-one for use in bacteria and one for use in mammalian cells-identified through a phylogenetic screen of candidate gas vesicle gene clusters from diverse bacteria and archaea that provide stronger ultrasound contrast, produce non-linear signals distinguishable from background tissue and have stable long-term expression. Compared to their first-generation counterparts, these improved bacterial and mammalian ARGs produce 9-fold and 38-fold stronger non-linear contrast, respectively. Using these new ARGs, we non-invasively imaged in situ tumor colonization and gene expression in tumor-homing therapeutic bacteria, tracked the progression of tumor gene expression and growth in a mouse model of breast cancer, and performed gene-expression-guided needle biopsies of a genetically mosaic tumor, demonstrating non-invasive access to dynamic biological processes at centimeter depth.


Subject(s)
Neoplasms , Animals , Mice , Genes, Reporter/genetics , Phylogeny , Neoplasms/genetics , Neoplasms/therapy , Bacteria/genetics , Acoustics , Mammals
16.
Anal Chem ; 94(44): 15525-15533, 2022 11 08.
Article in English | MEDLINE | ID: mdl-36310422

ABSTRACT

As a strategy that induces gene silencing by the delivery of small interfering RNA (siRNA) targeting a specific gene locus into cells or tissues, RNA interference (RNAi) technology holds the potential to be a powerful tool in a range of intractable disorder therapeutics. However, reliable noninvasive probes for visualizing the siRNA delivery and silencing efficiency have become a major obstacle in siRNA-based treatment. Here, we describe the development of an RNA-binding protein Pumilio/FBF (PUF)-based reporter probe for the monitoring of siRNA delivery efficiency and functional screening of effective siRNA target sites in vivo. This reporter consisted of a Firefly luciferase (Fluc) gene whose expression is regulated by the unique interaction architecture of the PUF protein with its Nanos response element (NRE) target RNA. We showed that a robust and rapid increase in the luminescence signal was detected by the successful delivery of siRNA against the enhanced green fluorescent protein (EGFP) or p53 genes into mammalian cells or the livers of mice. The delivery efficiencies of various commercial transfection vehicles were quantitatively evaluated with this reporter. In addition, we also employed in vivo bioluminescence imaging to screen and identify the most potent siRNA targeting p53. Our study indicates that the positive-readout reporter represents a promising indicator for siRNA optimization and visualization, advancing the development of siRNA therapeutic products.


Subject(s)
Gene Silencing , Mammals , Mice , Animals , RNA Interference , RNA, Small Interfering/genetics , Genes, Reporter/genetics , Transfection
17.
Trends Genet ; 38(10): 996-998, 2022 10.
Article in English | MEDLINE | ID: mdl-35641343

ABSTRACT

MRI-based gene reporters allow imaging of gene expression at depth (tens of centimetres) and at relatively high resolution (~10-100 µm) and have the potential to be translated to the clinic. The reporters exploit either endogenous contrast mechanisms or they modulate the response to an introduced exogenous contrast agent.


Subject(s)
Genes, Reporter , Magnetic Resonance Imaging , Genes, Reporter/genetics , Image Enhancement/methods , Magnetic Resonance Imaging/methods
18.
Neoplasia ; 27: 100781, 2022 05.
Article in English | MEDLINE | ID: mdl-35381456

ABSTRACT

Cytotoxic CD8+ T cells are the primary effector cells mediating anti-tumor responses. In vivo monitoring of CD8+ T cells has broad implications for the development of novel cancer therapies. Here we describe the development of a genetically engineered mouse model (GEMM) in which CD8+ T cells are labeled with an optical reporter, enabling in vivo, longitudinal monitoring using bioluminescence imaging (BLI). Firefly luciferase (Luc2), human diphtheria toxin receptor (DTR), and enhanced green fluorescence protein (eGFP) cDNAs are engineered under the CD8α promoter to generate a transgenic mouse line. Luciferase mRNA and CD8α mRNA were generally correlated in various tissues from these mice. Sorted splenic CD8+ T cells, CD4+ T cells and CD3- non-T cells verified that the luciferase signal is specific to CD8+ T cells. In vivo imaging showed that luciferase signal was detected in various immune organs, such as lymph nodes, thymus, and spleen, and the detection was confirmed by ex vivo examination. Administration of diphtheria toxin markedly reduced luciferase signal systemically, confirming the function of the DTR. In the MC38 mouse syngeneic model, we observed significant increases in CD8+ T cells with mDX400 treatment, an anti PD-1 mouse monoclonal antibody that correlated with tumor growth inhibition. This novel reporter GEMM is a valuable drug discovery tool for profiling compounds and understanding mechanisms of action in immunotherapy of cancer.


Subject(s)
CD8-Positive T-Lymphocytes , Luciferases , Animals , Antibodies, Monoclonal , Cell Line, Tumor , Disease Models, Animal , Genes, Reporter/genetics , Luciferases/genetics , Luciferases/metabolism , Luminescent Measurements , Mice , Mice, Transgenic , RNA, Messenger/metabolism
19.
J Virol ; 96(7): e0185821, 2022 04 13.
Article in English | MEDLINE | ID: mdl-35293773

ABSTRACT

Self-amplifying (sa) RNA molecules-"replicons"-derived from the genomes of positive-sense RNA viruses are receiving increasing attention as gene and vaccine delivery vehicles. This is because mRNA forms of genes of interest can be incorporated into them and strongly amplified, thereby enhancing target protein expression. In this report, we demonstrate a nonmonotonic dependence of protein expression on the mass of transfected replicon, in contrast to the usual, monotonic case of non-saRNA transfections. We lipotransfected a variety of cell lines with increasing masses of enhanced yellow fluorescent protein (eYFP) as a reporter gene in sa form and found that there is a "sweet spot" at which protein expression and cell viability are optimum. To control the varying mass of transfected replicon RNA for a given mass of Lipofectamine, the replicons were mixed with a "carrier" RNA that is neither replicated nor translated; the total mass of transfected RNA was kept constant while increasing the fraction of the replicon from zero to one. Fluorescence microscopy studies showed that the optimum protein expression and cell viability are achieved for replicon fractions as small as 1/10 of the total transfected RNA, and these results were quantified by a systematic series of flow cytometry measurements. IMPORTANCE Positive-sense RNA viruses often have a cytotoxic effect on their host cell because of the strength of their RNA replicase proteins, even though only one copy of their genome begins the viral life cycle in each cell. Noninfectious forms of them-replicons-which include just their RNA replication-related genes, are also strongly self-amplifying and cytotoxic. Accordingly, when replicons fused with nonviral genes of interest are transfected into cells to amplify expression of proteins of interest, one needs to keep the replicon "dose" sufficiently low. We demonstrate how to control the number of RNA replicons getting into transfected cells and that there is a sweet spot for the replicon dose that optimizes protein expression and cell viability. Examples are given for the case of Nodamura viral replicons with fluorescent protein reporter genes in a variety of mammalian cell lines, quantified by flow cytometry and live/dead cell assays.


Subject(s)
Protein Biosynthesis , RNA , Replicon , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Line , Genes, Reporter/genetics , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Mammals/genetics , Protein Biosynthesis/genetics , RNA/genetics , RNA, Viral/genetics , Replicon/genetics , Transfection
20.
IEEE Trans Biomed Eng ; 69(8): 2524-2532, 2022 08.
Article in English | MEDLINE | ID: mdl-35133958

ABSTRACT

The non-viral delivery of the prokaryotic clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (Cas9) nuclease system provides promising solutions for gene therapy. However, traditional chemical and physical delivery approaches for gene knock-in are confronted by significant challenges to overcome the drawbacks of low efficiency and high toxicity. An alternative method for directly delivering CRISPR components into single cells is microinjection. Here, we present the high-throughput robotic microinjection of CRISPR machinery plasmids to produce gene insertions. We demonstrate that the microinjection of CRISPR/Cas9 with an enhanced green fluorescent protein (eGFP) donor template into single HepG2 cells can achieve reporter gene knock-in targeting the adeno-associated virus site 1 locus. Homology-directed repair-mediated knock-in can be observed with an efficiency of 41%. Assessment via T7E1 assay indicates that the eGFP knock-in cells exhibit no detectable changes at potential off-target sites. A case study of injecting the eGFP knock-in cells into zebrafish (Danio rerio) embryos to form an in vivo tumor model is conducted. Results demonstrate the efficiency of combining microinjection with the CRISPR/Cas9 system in achieving gene knock-in.


Subject(s)
CRISPR-Cas Systems , Zebrafish , Animals , CRISPR-Cas Systems/genetics , Gene Knock-In Techniques , Genes, Reporter/genetics , Microinjections , Zebrafish/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...